Compare SSNC & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSNC | WST |
|---|---|---|
| Founded | 1986 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 18.5B |
| IPO Year | 2007 | 2004 |
| Metric | SSNC | WST |
|---|---|---|
| Price | $69.31 | $297.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $96.13 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 2.4M | 869.2K |
| Earning Date | 04-23-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.55% | 0.30% |
| EPS Growth | ★ 5.00 | 1.49 |
| EPS | ★ 3.15 | 1.92 |
| Revenue | $1,675,295,000.00 | ★ $2,886,900,000.00 |
| Revenue This Year | $9.20 | $6.76 |
| Revenue Next Year | $4.69 | $6.22 |
| P/E Ratio | ★ $22.05 | $153.84 |
| Revenue Growth | ★ 13.09 | 1.95 |
| 52 Week Low | $65.05 | $203.74 |
| 52 Week High | $91.07 | $322.34 |
| Indicator | SSNC | WST |
|---|---|---|
| Relative Strength Index (RSI) | 46.08 | 66.82 |
| Support Level | $65.05 | $234.43 |
| Resistance Level | $72.89 | $321.34 |
| Average True Range (ATR) | 1.78 | 8.50 |
| MACD | 0.01 | 1.96 |
| Stochastic Oscillator | 43.71 | 64.60 |
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.